Uncommon Cents Investing LLC Acquires 820 Shares of Medtronic PLC $MDT

Uncommon Cents Investing LLC increased its position in shares of Medtronic PLC (NYSE:MDT) by 2.6% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 32,717 shares of the medical technology company’s stock after buying an additional 820 shares during the period. Uncommon Cents Investing LLC’s holdings in Medtronic were worth $2,852,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Burkett Financial Services LLC grew its stake in shares of Medtronic by 185.0% in the 1st quarter. Burkett Financial Services LLC now owns 285 shares of the medical technology company’s stock valued at $26,000 after purchasing an additional 185 shares during the last quarter. 1248 Management LLC acquired a new stake in shares of Medtronic during the 1st quarter valued at about $26,000. Columbia River Financial Group LLC bought a new position in shares of Medtronic in the first quarter worth about $28,000. Twin Tree Management LP acquired a new stake in Medtronic during the first quarter valued at approximately $29,000. Finally, Activest Wealth Management lifted its holdings in Medtronic by 3,577.8% during the 1st quarter. Activest Wealth Management now owns 331 shares of the medical technology company’s stock worth $30,000 after buying an additional 322 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Buying and Selling at Medtronic

In related news, EVP Harry Skip Kiil sold 8,605 shares of the stock in a transaction dated Wednesday, September 3rd. The shares were sold at an average price of $91.58, for a total value of $788,045.90. Following the sale, the executive vice president directly owned 35,615 shares of the company’s stock, valued at approximately $3,261,621.70. This represents a 19.46% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director William R. Jellison acquired 2,500 shares of the stock in a transaction on Monday, August 25th. The stock was purchased at an average cost of $92.37 per share, with a total value of $230,925.00. Following the transaction, the director directly owned 5,000 shares of the company’s stock, valued at $461,850. This represents a 100.00% increase in their ownership of the stock. The disclosure for this purchase can be found here. Company insiders own 0.26% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on MDT. William Blair raised shares of Medtronic to a “hold” rating in a report on Friday, July 11th. Morgan Stanley reaffirmed an “overweight” rating and set a $107.00 target price (up previously from $98.00) on shares of Medtronic in a research note on Tuesday, July 15th. Leerink Partners assumed coverage on shares of Medtronic in a research note on Monday, June 16th. They set an “outperform” rating and a $110.00 price target on the stock. Citigroup lifted their target price on shares of Medtronic from $99.00 to $101.00 and gave the stock a “buy” rating in a research note on Thursday, August 21st. Finally, BTIG Research restated a “neutral” rating on shares of Medtronic in a research note on Friday, July 11th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $102.27.

Medtronic Stock Performance

MDT opened at $94.34 on Friday. Medtronic PLC has a 1 year low of $79.29 and a 1 year high of $96.25. The company has a market capitalization of $121.01 billion, a price-to-earnings ratio of 25.99, a P/E/G ratio of 2.48 and a beta of 0.77. The company has a debt-to-equity ratio of 0.54, a current ratio of 2.01 and a quick ratio of 1.50. The business’s 50-day moving average price is $92.57 and its two-hundred day moving average price is $88.38.

Medtronic (NYSE:MDT) last released its quarterly earnings data on Tuesday, August 19th. The medical technology company reported $1.26 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.23 by $0.03. The company had revenue of $8.58 billion for the quarter, compared to analysts’ expectations of $8.37 billion. Medtronic had a net margin of 13.63% and a return on equity of 14.61%. The business’s revenue was up 7.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.23 EPS. Medtronic has set its FY 2026 guidance at 5.600-5.660 EPS. Equities analysts expect that Medtronic PLC will post 5.46 EPS for the current fiscal year.

Medtronic Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 17th. Shareholders of record on Friday, September 26th will be paid a dividend of $0.71 per share. The ex-dividend date is Friday, September 26th. This represents a $2.84 dividend on an annualized basis and a yield of 3.0%. Medtronic’s dividend payout ratio is presently 78.24%.

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.